Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1996-10-16
|
pubmed:abstractText |
Circulating concentrations of leptin ([leptin]) vary directly with body mass index and percentage body fat, and may thus constitute an afferent limb of a system regulating body fatness. We tested the hypotheses that: 1) Plasma [leptin] vary more directly with absolute fat mass than with fractional body fatness per se: and 2). The relationship between fat mass and [leptin] is significantly affected by gender and by menopausal status. [Leptin] in the post-absorptive state was examined in 67 subjects (26 male, 20 premenopausal female, 21 postmenopausal females; 43 never-obese, 24 obese) at usual body weight. Body composition was determined by hydrodensitometry, and [leptin] was determined by a double antibody ELISA assay. In male and pre-menopausal female subjects, subcutaneous adipose tissue aspirations were performed for determination of adipocyte volume by the osmium fixation method, and a 3 hour oral glucose tolerance tests was performed. At usual body weight, ([leptin]) was better correlated with absolute fat mass than with body mass index (BMI) or percentage body fat. BMI and % body fat did not account for any of the variance in [leptin] beyond that attributable to FM, per se. The regression equations relating FM to [leptin] did not differ significantly between obese and never-obese subjects. [Leptin] and fasting serum insulin concentrations were significantly correlated in males only. [Leptin] was significantly higher in pre- and post-menopausal females compared to males, even when [leptin] was corrected for differences in body composition (pre-menopausal females > post-menopausal females > males). While plasma [leptin], corrected for FM, declines significantly in women post-menopause, this decline is not sufficient to account for the striking sexual dimorphism in the relationship of leptin to fat mass. This sexual dimorphism is apparently also due, in part, to a suppressive effect of circulating androgens on [leptin].
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0021-972X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
81
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3424-7
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8784109-Adipose Tissue,
pubmed-meshheading:8784109-Adult,
pubmed-meshheading:8784109-Aged,
pubmed-meshheading:8784109-Aged, 80 and over,
pubmed-meshheading:8784109-Body Composition,
pubmed-meshheading:8784109-Body Mass Index,
pubmed-meshheading:8784109-Female,
pubmed-meshheading:8784109-Humans,
pubmed-meshheading:8784109-Leptin,
pubmed-meshheading:8784109-Male,
pubmed-meshheading:8784109-Menopause,
pubmed-meshheading:8784109-Middle Aged,
pubmed-meshheading:8784109-Postmenopause,
pubmed-meshheading:8784109-Premenopause,
pubmed-meshheading:8784109-Proteins,
pubmed-meshheading:8784109-Sex Characteristics
|
pubmed:year |
1996
|
pubmed:articleTitle |
Effects of gender, body composition, and menopause on plasma concentrations of leptin.
|
pubmed:affiliation |
Laboratory of Human Behavior and Metabolism, Rockefeller University, New York, NY 10021, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.
|